about
Current status of biomarker research in neurologyPre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendationsEpidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC.Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.Postprandial oxidative stress and gastrointestinal hormones: is there a link?Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.Differential acute postprandial effects of processed meat and isocaloric vegan meals on the gastrointestinal hormone response in subjects suffering from type 2 diabetes and healthy controls: a randomized crossover study.TPS, thymidine kinase, VEGF and endostatin in cytosol of thyroid tissue samples.May CTC technologies promote better cancer management?Optimal Use of Biomarkers in OncologyOverview of healthcare system in the Czech Republic.The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.Isocitrate dehydrogenase-1 mutations as prognostic biomarker in glioblastoma multiforme patients in West BohemiaTumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.The role of thymidine kinase in cancer diseases.New treatment paradigm for patients with anaplastic oligodendroglial tumors.[Biobanks European infrastructure].The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed.Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy.Portal vein embolisation with application of haematopoietic stem cells in patients with primarily or non-resectable colorectal liver metastases.Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib.Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy.Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation.Assessment of grading in newly-diagnosed glioma using 18F-fluorothymidine PET/CT.The Measurement of Intraocular Biomarkers in Various Stages of Proliferative Diabetic Retinopathy Using Multiplex xMAP Technology.Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.Procalcitonin levels in peritoneal dialysis patients.[Initial results of monitoring hepatitis E virus antibodies in selected population groups in the West Bohemia Region. Preliminary report]Asymptomatic abdominal aortic aneurysms show histological signs of progression: a quantitative histochemical analysis.
P50
Q26744505-F7788220-2F46-4D3D-B113-EB14BAF2852CQ26829035-966A4DEA-B262-41CF-88C6-8F9E1E8FDFA5Q27853308-DD9FBC17-AE91-43EF-927A-F3FC320246A4Q33965085-A6CBE8B4-5681-4CBB-A9F6-7962B871961DQ34070530-DC3C15AE-BEDE-41AF-97EF-8C6ED0C81FC1Q34125306-AF786A5E-2917-400A-82CE-422A5B7D3E30Q34184127-D63ACA5D-635C-4C38-9C5B-3AC3A54A8ABAQ34435375-C23FF8CD-9BD4-4361-8E3A-FCEDB654B140Q35016353-8291E2A7-8BDF-4C28-B7F7-E641FBED2469Q35963928-1779A7AE-FE4B-4ABA-A134-B91C21B350ABQ36031819-BC1BF8F6-D614-4400-A8D8-21A224039310Q36331824-A3DB20FE-DFC6-4D25-9F93-8B8CF7F666B6Q36826562-13C46FCA-15E2-4EEF-B95F-5DC109CF50C5Q37543351-F12EB878-3582-4288-82A9-E0715B7E91BEQ37582064-9A7D82FF-8FDF-4EEF-B911-522B5BCCA5BDQ38088840-3C66BAC0-D2DE-4751-8225-6E108D02D86DQ38201450-217EF106-632B-4508-A2DD-E7E8E606BD8AQ38379912-FDCA2BA7-81D8-4EB7-AC89-27485FCBDF0EQ38697130-1F69149D-2A5B-44D6-B1AC-D3A586EDAA52Q38796486-526BCD48-2747-42C7-80AC-D270E93E84E2Q38801363-5C001824-1241-442F-A5FB-E4E0D9598509Q38882469-263D66F5-DFF7-4D50-8ACD-245B5B0E5F40Q38952088-F90BCE35-3DC2-4EC2-8DF1-EA3FDB164557Q39076955-C949DD55-7274-4E2D-A1E7-701B45DD10ACQ39373031-232202D9-4C3B-4C46-B9BE-8233E71112A0Q39811379-CCDB4D7E-FA9A-483E-863F-9C76C458BE30Q39940792-9A933DFE-3DB3-420B-9BC8-3181ED3089B8Q40153505-F0EF4BCA-1576-42B6-902B-60729A7E6389Q40196465-337BA895-943F-4D66-B12D-5558040234DFQ40216854-F8E98F94-851E-46CC-B491-90F5973FDE98Q40718477-2A5422CC-DD73-4B7B-8A19-C9B15B2AE250Q40822344-5406B0C3-A118-4486-9121-67D407BCAAFFQ40853581-C493E554-4B36-4F07-9CAD-0D297A77229FQ41377253-ADAB0011-BE51-47E6-A592-4BD2A2D12A05Q41455928-7FA04769-2D60-41E9-B450-80939775CF95Q41896388-297B629A-9453-40FD-9292-539D581D900EQ42482681-F3DAD074-F0B5-4D70-BEED-53715BF10143Q43416784-A3E69F92-1BD3-431E-B072-50A419D04AE4Q43447441-701E0824-CED8-41E3-A408-53E1FBC4C212Q43509058-B1126B71-F66A-43F7-8FFD-B16D49CA49FE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ondrej Topolcan
@ast
Ondrej Topolcan
@en
Ondrej Topolcan
@es
Ondrej Topolcan
@nl
Ondrej Topolcan
@sl
type
label
Ondrej Topolcan
@ast
Ondrej Topolcan
@en
Ondrej Topolcan
@es
Ondrej Topolcan
@nl
Ondrej Topolcan
@sl
prefLabel
Ondrej Topolcan
@ast
Ondrej Topolcan
@en
Ondrej Topolcan
@es
Ondrej Topolcan
@nl
Ondrej Topolcan
@sl
P106
P31
P496
0000-0001-6622-390X